找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Radiation Oncology Study Guide; Ravi A. Chandra,Celine B. Ord,Charles R. Thomas Jr Textbook 2021Latest edition Springer Nature Switzerland

[復(fù)制鏈接]
樓主: 不讓做的事
21#
發(fā)表于 2025-3-25 03:25:17 | 只看該作者
Skin Cancer and Uveal Melanoma,in clinical staging per the American Joint Committee on Cancer and novel therapeutic agents. Given the rarity of uveal melanoma, this disease entity is briefly included in the same chapter as cutaneous melanoma as radiation is an integral component of management organ preservation.
22#
發(fā)表于 2025-3-25 11:12:48 | 只看該作者
Head and Neck Cancer,clude updates in clinical staging as introduced by the American Joint Committee on Cancer, management of HPV-positive oropharynx cancer, approaches to cervical node management, and new information on systemic regimens in the setting of concurrent or sequential chemoradiation.
23#
發(fā)表于 2025-3-25 12:38:35 | 只看該作者
Thoracic Cancer,herapy, and advancements in concurrent chemoradiation. This section has also been expanded to incorporate major studies in NSCLC highlighting dose escalation and the use of adjuvant immunotherapy. Also, this section includes role of consolidative radiation and prophylactic cranial radiation in SCLC.
24#
發(fā)表于 2025-3-25 19:43:43 | 只看該作者
25#
發(fā)表于 2025-3-25 21:25:17 | 只看該作者
26#
發(fā)表于 2025-3-26 00:31:20 | 只看該作者
27#
發(fā)表于 2025-3-26 08:06:18 | 只看該作者
28#
發(fā)表于 2025-3-26 08:55:03 | 只看該作者
Breast Cancer, mitigate toxicity. Additionally, molecular testing has opened up avenues for successful targeted agents and reassessment in radiation therapy strategies. This section has been expanded to incorporate the aforementioned evolution of breast radiotherapy.
29#
發(fā)表于 2025-3-26 13:13:03 | 只看該作者
30#
發(fā)表于 2025-3-26 19:10:38 | 只看該作者
Pediatric Non-CNS Tumors,kemia, lymphoma, neuroblastoma, Wilms’ tumor, Ewing sarcoma, rhabdomyosarcoma, and retinoblastoma. Similar to pediatric CNS tumors, treatment strategies for pediatric body tumors continue to evolve as we learn more about molecular markers and targeted novel therapies.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 11:44
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
郴州市| 开远市| 新巴尔虎左旗| 孙吴县| 隆昌县| 瓦房店市| 花莲市| 澜沧| 嘉荫县| 唐海县| 潞西市| 庐江县| 贺兰县| 政和县| 海晏县| 泗水县| 定州市| 泰和县| 阳曲县| 成武县| 黔西| 济南市| 百色市| 雅江县| 镇雄县| 霞浦县| 莱西市| 余姚市| 安乡县| 苍梧县| 镇安县| 丽水市| 瑞金市| 南阳市| 新龙县| 利川市| 江油市| 旬邑县| 和静县| 来宾市| 汉寿县|